Clinical Trial Update: Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes microbiota modification as a strategy to enhance immuno-oncology in hepatocellular carcinoma, and the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Center Eugene Marquis | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING